Michael William Pennington
Chief Tech/Sci/R&D Officer at Ambio Pharmaceuticals
Profile
Michael William Pennington's current job(s) include being the Chief Scientific Officer at Ambio Pharmaceuticals since 2021 and the Chief Scientific Officer at AmbioPharm, Inc. (South Carolina) since 2018.
Dr. Pennington's former job(s) include being the Chief Executive Officer at Peptides International LLC from 2012 to 2018 and the Chief Operating Officer at Bachem Bioscience, Inc. from 2000 to 2010.
Dr. Pennington obtained a doctorate degree from the University of Florida in 1988 and an undergraduate degree from The University of North Carolina at Chapel Hill in 1984.
Michael William Pennington active positions
| Companies | Position | Start |
|---|---|---|
Ambio Pharmaceuticals
 Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | Chief Tech/Sci/R&D Officer | 15/06/2021 |
AmbioPharm, Inc. (South Carolina)
 AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023. | Chief Tech/Sci/R&D Officer | 03/03/2019 |
Former positions of Michael William Pennington
| Companies | Position | End |
|---|---|---|
Peptides International LLC
 Peptides International LLC BiotechnologyHealth Technology Peptides International, Inc. manufactures and distributes biochemical products. It engages in research and development that complements the production of solid phase resins, amino acid derivatives, peptides, and related products. The company was founded by Arno. F. Spatola in 1983 and is headquartered in Louisville, KY. | Chief Executive Officer | 31/01/2018 |
| Bachem Bioscience, Inc. | Chief Operating Officer | 31/07/2010 |
Training of Michael William Pennington
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| University of Florida | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Peptides International LLC
Peptides International LLC BiotechnologyHealth Technology Peptides International, Inc. manufactures and distributes biochemical products. It engages in research and development that complements the production of solid phase resins, amino acid derivatives, peptides, and related products. The company was founded by Arno. F. Spatola in 1983 and is headquartered in Louisville, KY. | Health Technology |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | Commercial Services |
AmbioPharm, Inc. (South Carolina)
AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023. | Health Technology |
| Bachem Bioscience, Inc. |
- Stock Market
- Insiders
- Michael William Pennington
